CAMBRIDGE, Mass.--(BUSINESS WIRE)--Repertoire Immune Medicines, a clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious ...
June 29 (Reuters) - BioCryst Pharmaceuticals said on Monday it would wind down its internal drug discovery programs and close its Alabama research facility by the end of 2026, as it pivots to external ...
Anthropic has entered the AI healthcare race with a new drug discovery program focused on neglected diseases while also ...
The company will be transferring its Directors' Workshop and Writers' Workshop programs from its previous home at Warner Bros. Television to its Diversity, Equity and Inclusion division. By Katie ...
LEBANON, N.H.--(BUSINESS WIRE)-- Adimab, LLC, a technology leader in the discovery of fully human antibodies, today announced the initiation of two independent collaborations with Biogen Idec and Novo ...
ChemDiv, Inc. ( a global provider of integrated drug discovery solutions, today announced significant milestones achieved through its proprietary central nervous system (CNS) focused drug discovery ...
TORONTO & OXFORD, England--(BUSINESS WIRE)--Cyclica Inc. (“Cyclica”), a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline, and Arctoris Ltd. (“Arctoris”), ...